OX40 ligand: Difference between revisions
CSV import |
CSV import |
||
| Line 41: | Line 41: | ||
{{Immunology-stub}} | {{Immunology-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 20:32, 17 March 2025
OX40 Ligand (also known as OX40L, CD252 or TNFSF4) is a protein that in humans is encoded by the TNFSF4 gene. It is a member of the tumor necrosis factor (TNF) ligand family and plays a crucial role in the immune system.
Function[edit]
The OX40 Ligand is primarily expressed on activated antigen-presenting cells (APCs) and binds to the OX40 receptor found on the surface of T cells. This interaction between OX40L and OX40 receptor is essential for T cell proliferation and survival, as well as for the generation of long-lived memory cells and immunological synapse formation.
Clinical Significance[edit]
The OX40-OX40L interaction has been implicated in several autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus (SLE), and multiple sclerosis (MS). It is also involved in allergic diseases such as asthma and atopic dermatitis. Therefore, OX40L has been a target for therapeutic intervention in these diseases.
Therapeutic Applications[edit]
Several therapeutic strategies have been developed to block the OX40-OX40L interaction, including the use of monoclonal antibodies, fusion proteins, and small molecule inhibitors. These therapies have shown promise in preclinical and early clinical trials for the treatment of autoimmune and allergic diseases.
See Also[edit]
- OX40
- Tumor necrosis factor
- Antigen-presenting cell
- T cell
- Memory cell
- Immunological synapse
- Autoimmune disease
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Multiple sclerosis
- Asthma
- Atopic dermatitis
- Monoclonal antibody
- Fusion protein
- Small molecule inhibitor
References[edit]
<references group="" responsive="1"></references>

This article is a immunology stub. You can help WikiMD by expanding it!